[Case Study] Keiji Okinaka “A disseminated filamentous fungal infection that broke through echinocandin antifungal treatment” (AMR Alliance Japan, September 6, 2021 )
date : 9/6/2021
Tags: AMR
![[Case Study] Keiji Okinaka “A disseminated filamentous fungal infection that broke through echinocandin antifungal treatment” (AMR Alliance Japan, September 6, 2021 )](https://hgpi.xsrv.jp/en/wp-content/uploads/sites/2/AMR-case01_ENG.jpg)
AMR Alliance Japan (Secretariat: Health and Global Policy Institute (HGPI)) has begun a project to publish case studies showing actual cases in which antimicrobials were and were not used as examples of antimicrobial stewardship.
In this first case study, Dr. Keiji Okinaka (Director of Infection Control and Prevention Section, National Cancer Center Hospital East / Department of General Internal Medicine, National Cancer Center Hospital East /Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital) reports on a case of “A disseminated filamentous fungal infection that broke through echinocandin antifungal treatment.”
For further information, please see the case study below.
![[AMR Case Study 01] A disseminated filamentous fungal infection that broke through echinocandin antifungal treatment](/assets/img/katsudo/icon_pdf_l.png){kind=icon}
Top Research & Recommendations Posts
- [Research Report] The Public Opinion Survey on Mental Health (August 12, 2022)
- [Recommendations] Creating a Long-Term Care System for the Era of Healthy Longevity –Five Discussion Points Revealed by Current Circumstances and Three Perspectives For The Future (March 31, 2022)
- [Announcement] HGPI Planetary Health Policy Team Signs Healthy Climate Prescription (August 31, 2022)
- [Research Paper] “Association of Women’s Health Literacy and Work Productivity among Japanese Workers” Published in JMA Journal (July 15, 2020)
- [Research Report] Public Opinion Survey on Priorities for Policies Related to Children’s Health (January 17, 2022)
